Author:
Schimdt Nina,Jacob Louis,Coleman Robert,Kostev Karel,Hadji Peyman
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. World Cancer Research Fund International: Worldwide data. http://www.wcrf.org , 2015, Accessed 08 Feb 2015
2. World Cancer Research Fund International: Breast cancer statistics. http://www.wcrf.org , 2015, Accessed on 08 Feb 2015
3. Hadji P, Ziller V, Kyvernitakis J et al (2013) Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis. Breast Cancer Res Treat 138:185–191. doi: 10.1007/s10549-013-2417-1
4. Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary Breast cancer. J Clin Oncol 21:602–606. doi: 10.1200/JCO.2003.07.071
5. Goss PE, Ingle JN, Martino S et al (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97:1262–1271. doi: 10.1093/jnci/dji250
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献